KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intuitive Surgical (ISRG) Accumulated Expenses (2016 - 2025)

Intuitive Surgical (ISRG) has 17 years of Accumulated Expenses data on record, last reported at $648.4 million in Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 21.06% year-over-year to $648.4 million; the TTM value through Dec 2025 reached $648.4 million, up 21.06%, while the annual FY2025 figure was $648.4 million, 21.06% up from the prior year.
  • Accumulated Expenses reached $648.4 million in Q4 2025 per ISRG's latest filing, up from $455.5 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $648.4 million in Q4 2025 and bottomed at $194.8 million in Q1 2021.
  • Average Accumulated Expenses over 5 years is $349.9 million, with a median of $334.0 million recorded in 2023.
  • Peak YoY movement for Accumulated Expenses: skyrocketed 51.43% in 2021, then fell 8.62% in 2024.
  • A 5-year view of Accumulated Expenses shows it stood at $350.1 million in 2021, then increased by 14.71% to $401.6 million in 2022, then increased by 8.67% to $436.4 million in 2023, then grew by 22.73% to $535.6 million in 2024, then increased by 21.06% to $648.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Expenses were $648.4 million in Q4 2025, $455.5 million in Q3 2025, and $420.8 million in Q2 2025.